YorkBridge Wealth Partners’s ANI Pharmaceuticals ANIP Stock Holding History

YorkBridge Wealth Partners’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-152	Closed	-$12K	–	190
2019 Q2	$12K	Sell	152 -59	-28%	-$4.2K	0.01%	515
2019 Q1	$15K	Sell	211 -24	-10%	-$1.41K	0.01%	500
2018 Q4	$11K	Sell	235 -128	-35%	-$6.71K	0.01%	555
2018 Q3	$20K	Hold	363	–	–	0.01%	518
2018 Q2	$24K	Hold	363	–	–	0.01%	485
2018 Q1	$22K	Buy	363 +47	+15%	+$2.98K	0.01%	492
2017 Q4	$18K	Sell	316 -13	-4%	-$809	0.01%	540
2017 Q3	$17K	Buy	329 +3	+0.9%	+$143	0.01%	557
2017 Q2	$15K	Hold	326	–	–	0.01%	569
2017 Q1	$18K	Buy	326 +198	+155%	+$11.1K	0.01%	527
2016 Q4	$8K	Buy	+128	New	+$7.83K	﹤0.01%	625

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

YorkBridge Wealth Partners's ANIP Position: Q3 2019 in Review

YorkBridge Wealth Partners sold out of ANI Pharmaceuticals (ANIP) in Q3 2019, closing a stake of 152 shares — an estimated $12K sold.

YorkBridge Wealth Partners first reported a position in ANIP in Q4 2016 and held it in 11 quarters. The position peaked at $24K in Q2 2018. 190 funds tracked by Wall St. Rank hold ANIP as of Q3 2019.

YorkBridge Wealth Partners reported no remaining ANI Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
YorkBridge Wealth Partners sold 152 ANI Pharmaceuticals shares in Q3 2019, an estimated $12K.
YorkBridge Wealth Partners first reported a position in ANI Pharmaceuticals in Q4 2016 and held it in 11 quarters.
YorkBridge Wealth Partners's ANI Pharmaceuticals position peaked at $24K in Q2 2018.
190 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q3 2019.

Based on YorkBridge Wealth Partners's 13F filing for Q3 2019, filed 21 Oct 2019.